CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS

The invention is directed to substituted bridged cycloalkane derivatives. Specifically, the invention is directed to compounds according to Formula (IIIQ): wherein X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AXTEN, Jeffrey Michael, KALITA, Biswajit, EVANS, Karen Anderson, RALPH, Jeffrey M, DEMARTINO, Michael P
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator AXTEN, Jeffrey Michael
KALITA, Biswajit
EVANS, Karen Anderson
RALPH, Jeffrey M
DEMARTINO, Michael P
description The invention is directed to substituted bridged cycloalkane derivatives. Specifically, the invention is directed to compounds according to Formula (IIIQ): wherein X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85', and z86' are as defined herein; or salts thereof. The compounds of the invention are inhibitors of the ATF4 pathway. Accordingly, invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting the ATF4 pathway and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention. L'invention concerne des dérivés de cycloalcanes pontés substitués. L'invention concerne particulièrement des composés de formule (IIIQ) : dans laquelle X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85' et z86' sont tels que définis dans la description ; ou leurs sels. Les composés selon l'invention sont des inhibiteurs de la voie ATF4. Par conséquent, l'invention concerne également des compositions pharmaceutiques comprenant un composé selon l'invention. L'invention concerne enfin des procédés d'inhibition de la voie ATF4 et le traitement de troubles associés, au moyen d'un composé de l'invention ou d'une composition pharmaceutique comprenant un composé de l'invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2018225093A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2018225093A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2018225093A13</originalsourceid><addsrcrecordid>eNrjZNB19nD19XR29FFw9vcN8A_1cwlWcASiEDcThQDHEI9wx0gFTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgaGFkZGpgaexoaEycKgBGqiZO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS</title><source>esp@cenet</source><creator>AXTEN, Jeffrey Michael ; KALITA, Biswajit ; EVANS, Karen Anderson ; RALPH, Jeffrey M ; DEMARTINO, Michael P</creator><creatorcontrib>AXTEN, Jeffrey Michael ; KALITA, Biswajit ; EVANS, Karen Anderson ; RALPH, Jeffrey M ; DEMARTINO, Michael P</creatorcontrib><description>The invention is directed to substituted bridged cycloalkane derivatives. Specifically, the invention is directed to compounds according to Formula (IIIQ): wherein X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85', and z86' are as defined herein; or salts thereof. The compounds of the invention are inhibitors of the ATF4 pathway. Accordingly, invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting the ATF4 pathway and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention. L'invention concerne des dérivés de cycloalcanes pontés substitués. L'invention concerne particulièrement des composés de formule (IIIQ) : dans laquelle X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85' et z86' sont tels que définis dans la description ; ou leurs sels. Les composés selon l'invention sont des inhibiteurs de la voie ATF4. Par conséquent, l'invention concerne également des compositions pharmaceutiques comprenant un composé selon l'invention. L'invention concerne enfin des procédés d'inhibition de la voie ATF4 et le traitement de troubles associés, au moyen d'un composé de l'invention ou d'une composition pharmaceutique comprenant un composé de l'invention.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20181213&amp;DB=EPODOC&amp;CC=WO&amp;NR=2018225093A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20181213&amp;DB=EPODOC&amp;CC=WO&amp;NR=2018225093A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AXTEN, Jeffrey Michael</creatorcontrib><creatorcontrib>KALITA, Biswajit</creatorcontrib><creatorcontrib>EVANS, Karen Anderson</creatorcontrib><creatorcontrib>RALPH, Jeffrey M</creatorcontrib><creatorcontrib>DEMARTINO, Michael P</creatorcontrib><title>CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS</title><description>The invention is directed to substituted bridged cycloalkane derivatives. Specifically, the invention is directed to compounds according to Formula (IIIQ): wherein X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85', and z86' are as defined herein; or salts thereof. The compounds of the invention are inhibitors of the ATF4 pathway. Accordingly, invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting the ATF4 pathway and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention. L'invention concerne des dérivés de cycloalcanes pontés substitués. L'invention concerne particulièrement des composés de formule (IIIQ) : dans laquelle X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85' et z86' sont tels que définis dans la description ; ou leurs sels. Les composés selon l'invention sont des inhibiteurs de la voie ATF4. Par conséquent, l'invention concerne également des compositions pharmaceutiques comprenant un composé selon l'invention. L'invention concerne enfin des procédés d'inhibition de la voie ATF4 et le traitement de troubles associés, au moyen d'un composé de l'invention ou d'une composition pharmaceutique comprenant un composé de l'invention.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB19nD19XR29FFw9vcN8A_1cwlWcASiEDcThQDHEI9wx0gFTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgaGFkZGpgaexoaEycKgBGqiZO</recordid><startdate>20181213</startdate><enddate>20181213</enddate><creator>AXTEN, Jeffrey Michael</creator><creator>KALITA, Biswajit</creator><creator>EVANS, Karen Anderson</creator><creator>RALPH, Jeffrey M</creator><creator>DEMARTINO, Michael P</creator><scope>EVB</scope></search><sort><creationdate>20181213</creationdate><title>CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS</title><author>AXTEN, Jeffrey Michael ; KALITA, Biswajit ; EVANS, Karen Anderson ; RALPH, Jeffrey M ; DEMARTINO, Michael P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2018225093A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>AXTEN, Jeffrey Michael</creatorcontrib><creatorcontrib>KALITA, Biswajit</creatorcontrib><creatorcontrib>EVANS, Karen Anderson</creatorcontrib><creatorcontrib>RALPH, Jeffrey M</creatorcontrib><creatorcontrib>DEMARTINO, Michael P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AXTEN, Jeffrey Michael</au><au>KALITA, Biswajit</au><au>EVANS, Karen Anderson</au><au>RALPH, Jeffrey M</au><au>DEMARTINO, Michael P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS</title><date>2018-12-13</date><risdate>2018</risdate><abstract>The invention is directed to substituted bridged cycloalkane derivatives. Specifically, the invention is directed to compounds according to Formula (IIIQ): wherein X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85', and z86' are as defined herein; or salts thereof. The compounds of the invention are inhibitors of the ATF4 pathway. Accordingly, invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting the ATF4 pathway and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention. L'invention concerne des dérivés de cycloalcanes pontés substitués. L'invention concerne particulièrement des composés de formule (IIIQ) : dans laquelle X6', a, b, C8', D8', L82', L83', R81', R82', R83', R84', R85', R86', z82', z84', z85' et z86' sont tels que définis dans la description ; ou leurs sels. Les composés selon l'invention sont des inhibiteurs de la voie ATF4. Par conséquent, l'invention concerne également des compositions pharmaceutiques comprenant un composé selon l'invention. L'invention concerne enfin des procédés d'inhibition de la voie ATF4 et le traitement de troubles associés, au moyen d'un composé de l'invention ou d'une composition pharmaceutique comprenant un composé de l'invention.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2018225093A1
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CHEMICAL COMPOUNDS AS ATF4 PATHWAY INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T05%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AXTEN,%20Jeffrey%20Michael&rft.date=2018-12-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2018225093A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true